PureTech Health plc
PRTC.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | £27,782 | -£66,628 | -£37,065 | -£62,709 |
| Dep. & Amort. | £3,571 | £4,933 | £8,893 | £7,287 |
| Deferred Tax | £0 | £0 | £0 | -£112,613 |
| Stock-Based Comp. | £22,850 | £4,415 | £14,698 | £13,950 |
| Change in WC | -£10,236 | £13,958 | £15,919 | £861 |
| Other Non-Cash | -£178,336 | -£62,595 | -£181,237 | -£5,050 |
| Operating Cash Flow | -£134,369 | -£105,917 | -£178,792 | -£158,274 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£11 | -£70 | -£2,176 | -£5,661 |
| Net Acquisitions | -£105,970 | -£13,784 | -£20,440 | £321 |
| Inv. Purchases | -£309,602 | -£195,710 | -£268,733 | -£500 |
| Inv. Sales/Matur. | £656,216 | £277,865 | £183,710 | £218,125 |
| Other Inv. Act. | £255 | £690 | £416 | -£14,910 |
| Investing Cash Flow | £240,888 | £68,991 | -£107,223 | £197,375 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -£3,394 | -£3,338 | -£4,025 | -£3,375 |
| Stock Issued | £895 | £1,153 | £332 | £0 |
| Stock Repurch. | -£107,559 | -£19,650 | -£26,492 | -£13,331 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £93,100 | £99,976 | £358 | £39,081 |
| Financing Cash Flow | -£16,958 | £78,141 | -£29,827 | £22,727 |
| Forex Effect | £0 | £0 | £0 | -£1 |
| Net Chg. in Cash | £89,560 | £41,215 | -£315,842 | £61,827 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £191,081 | £149,866 | £465,708 | £403,881 |
| End Cash | £280,641 | £191,081 | £149,866 | £465,708 |
| Free Cash Flow | -£134,380 | -£106,162 | -£180,968 | -£163,935 |